Invesco Biotechnology & Genome ETF (PBE) Holdings $70.92 -0.63 (-0.87%) As of 10:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 PBE HoldingsRankCompanyCurrent PriceWeightShares Held1BIIBBiogen$149.61-0.9%4.95%78,8702INCYIncyte$84.75-0.7%4.92%128,3723RPRXRoyalty Pharma$36.14+0.3%4.88%299,7014GILDGilead Sciences$116.74-1.3%4.87%93,9725REGNRegeneron Pharmaceuticals$569.90+1.1%4.82%18,3506VRTXVertex Pharmaceuticals$414.86-1.5%4.78%27,8617AMGNAmgen$295.43+0.3%4.74%37,2378ILMNIllumina$96.45-1.4%4.70%109,2199IONSIonis Pharmaceuticals$70.27+0.4%4.06%139,47810UTHRUnited Therapeutics$445.38-0.8%3.80%19,022 Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 11MNKDMannKind$5.14-5.5%3.51%1,445,14812PTCTPTC Therapeutics$66.01+2.4%3.22%118,92013EXASExact Sciences$59.46+0.2%3.09%127,55914VCYTVeracyte$34.93-0.5%3.01%202,33115NBIXNeurocrine Biosciences$138.47-0.4%2.87%42,98316HALOHalozyme Therapeutics$65.11-0.1%2.78%80,62917EXELExelixis$38.57-0.2%2.72%153,41118MDGLMadrigal Pharmaceuticals$428.30-2.0%2.69%13,84419SRPTSarepta Therapeutics$23.13-1.1%2.68%322,11220CPRXCatalyst Pharmaceuticals$20.82+2.1%2.65%294,97321DVAXDynavax Technologies$10.35+1.7%2.56%563,38622BMRNBioMarin Pharmaceutical$53.85-1.5%2.51%102,38023QGENQiagen$46.99-1.6%2.47%120,38024COLLCollegium Pharmaceutical$33.21+0.2%2.44%152,55925BCRXBioCryst Pharmaceuticals$7.25-0.4%2.43%685,519 Geographic ExposureUnited States97.5%Netherlands2.5%Currency ExposureUSD97.5%Sector ExposureHealth Care95.4%Materials2.5%Industrials2.1%Industry ExposureBiotechnology79.1%Health Care Equipment & Supplies16.3%Metals & Mining2.5%Commercial Services & Supplies2.1%SubIndustry ExposureBiotechnology79.1%Life Sciences Tools & Services16.3%Diversified Metals & Mining2.5%Pharmaceuticals2.1% Related Companies and Tools Related Companies SPDR S&P Pharmaceuticals ETF Portfolio Direxion Daily Healthcare Bull 3x Shares Portfolio Invesco Pharmaceuticals ETF Portfolio Simplify Health Care ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio KraneShares MSCI All China Health Care Index ETF Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio VanEck Biotech ETF Portfolio ALPS Medical Breakthroughs ETF Portfolio This page (NYSEARCA:PBE) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
